• Other
  • Exited

Aires Pharmaceuticals, Inc., a clinical stage pharmaceutical company, developed therapies to treat pulmonary disorders. The company offered Aironite, an inhaled drug that is used to treat adult and pediatric pulmonary hypertension, cystic fibrosis, pneumonia, and other respiratory infections. It also developed products for the treatment of bacterial pulmonary infections. Aires Pharmaceuticals was acquired by Mast Therapeutics in February 2014.